Global Gastritis Treatment Market Size, Status and Forecast 2019-2025

SKU ID : QYR-13717275

Publishing Date : 09-Jan-2019

No. of pages : 94


  • Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.
    The Americas is going to account for the largest share for gastritis treatment market. Drivers such as widespread of fast food chains in this region along with the increasing sedentary life culture which in turn contributes to increasing patient pool of gastritis and rising geriatric population are likely to enhance the growth of gastritis treatment market.
    Europe is the second market leader and holds a healthy share in the global gastritis treatment market. The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities, established healthcare infrastructure along with the presence of a flourishing medical device market which helps in efficient and accurate diagnosis. Furthermore, due to the increasing number of lactose-intolerant issues, vulnerability to falling prey of gastritis is more likely to lead to an increasing number of gastritis sufferers. Thus, fueling the market growth during the forecast period.
    Asia-Pacific is expected to be the fastest emerging market owing to increasing government initiatives for healthcare reform, increasing adaption of a sedentary lifestyle, and increasing prevalence of gastritis. Moreover, the prevalence of multifocal atrophic gastritis and gastric adenocarcinomas is high in these regions. Furthermore, the presence of renowned domestic pharmaceutical players, as well as the increasing healthcare spending per capita, is going to accelerate the market growth during the forecast period.
    In 2018, the global Gastritis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Gastritis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastritis Treatment development in United States, Europe and China.

    The key players covered in this study
    Abbott Laboratories
    Reddy's Laboratories
    Lupin Ltd
    Perrigo Pharmaceutical
    Sun Pharmaceutical Industries

    Market segment by Type, the product can be split into
    Acid-Blocking Medicines
    Histamine Blockers

    Market segment by Application, split into

    Market segment by Regions/Countries, this report covers
    United States
    Southeast Asia
    Central & South America

    The study objectives of this report are:
    To analyze global Gastritis Treatment status, future forecast, growth opportunity, key market and key players.
    To present the Gastritis Treatment development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Gastritis Treatment are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.